Safety study of an experimental oral drug in healthy adults
This study tests a new oral investigational drug in healthy adults to see how safe it is and how the body handles it. It is an early-phase trial that helps determine the right dose and check for side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 55 years old
- Generally good health, with normal heart, blood pressure, and lab tests
- Weight of at least 99 lbs (45 kg), and body mass index (BMI) between 18.5 and 30
- No immediate family history of serious heart rhythm problems or sudden cardiac death before age 50
- No personal history of certain mental health conditions, such as schizophrenia or severe depression, or substance abuse within the past 5 years
- Will avoid alcohol, certain medications, and other restrictions during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug called JZP047 in healthy volunteers. Researchers want to see how safe it is, how the body processes it, and whether taking it with food changes its effects.
This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.
This study tests a new oral drug called ALZ-507, which is being developed for Alzheimer's disease. It is an early-phase trial to check the drug's safety and how it is processed in the body, in healthy older adults.
This study tests a new medicine called ZP9830 to see if it is safe for people and how it works in the body. Healthy volunteers aged 18 to 45 can join.
This early-stage trial tests a new oral drug (ZE66-0205) for the first time in healthy people to see how safe it is and how the body handles it. The results will guide future studies for patients.
This is an early-stage safety study testing a new investigational drug (VH4770359) in healthy volunteers. Researchers want to understand how the body processes the drug and ensure it is safe and well-tolerated.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.